Abstract | BACKGROUND: In the 2022 mpox (monkeypox) outbreak, 79,000 global cases have been reported. Yet, limited dermatologic data have been published regarding lesion morphology and progression. OBJECTIVE: The objective of this study was to characterize skin lesion morphology, symptomatology, and outcomes of mpox infection over time. METHODS: The American Academy of Dermatology/International League of Dermatological Societies Dermatology COVID-19, Mpox, and Emerging Infections Registry captured deidentified patient cases of mpox entered by health care professionals. RESULTS: From August 4 to November 13, 2022, 101 cases from 13 countries were entered, primarily by dermatologists (92%). Thirty-nine percent had fewer than 5 lesions. In 54% of cases, skin lesions were the first sign of infection. In the first 1-5 days of infection, papules (36%), vesicles (17%), and pustules (20%) predominated. By days 6-10, pustules (36%) were most common, followed by erosions/ ulcers (27%) and crusts/scabs (24%). Crusts/scabs were the predominant morphology after day 11. Ten cases of morbilliform rash were reported. Scarring occurred in 13% of the cases. LIMITATIONS: Registry-reported data cannot address incidence. There is a potential reporting bias from the predilection to report cases with greater clinical severity. DISCUSSION: These findings highlight differences in skin findings compared to historical outbreaks, notably the presence of skin lesions prior to systemic symptoms and low overall lesion counts. Scarring emerged as a major possible sequela.
|
Authors | Sonya Prasad, Cristina Galvan Casas, Alexis G Strahan, L Claire Fuller, Klint Peebles, Andrea Carugno, Kieron S Leslie, Joanna L Harp, Teodora Pumnea, Devon E McMahon, Misha Rosenbach, Janet E Lubov, Geoffrey Chen, Lindy P Fox, Allen McMillen, Henry W Lim, Alexander J Stratigos, Terrence A Cronin, Mark D Kaufmann, George J Hruza, Lars E French, Esther E Freeman |
Journal | Journal of the American Academy of Dermatology
(J Am Acad Dermatol)
Vol. 88
Issue 5
Pg. 1066-1073
(05 2023)
ISSN: 1097-6787 [Electronic] United States |
PMID | 36641010
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2023. Published by Elsevier Inc. |
Topics |
- Humans
- Cicatrix
- Mpox (monkeypox)
- COVID-19
(epidemiology)
- Skin Diseases
- Disease Outbreaks
- Blister
- Disease Progression
|